Literature DB >> 13175011

The therapeutic value of lysergic acid diethylamide in mental illness.

R A SANDISON, A M SPENCER, J D WHITELAW.   

Abstract

Entities:  

Keywords:  ERGOT ALKALOIDS/therapeutic use; MENTAL DISORDERS/therapy

Mesh:

Substances:

Year:  1954        PMID: 13175011     DOI: 10.1192/bjp.100.419.491

Source DB:  PubMed          Journal:  J Ment Sci        ISSN: 0368-315X


× No keyword cloud information.
  24 in total

Review 1.  [PSYCHODYSLEPTIC DRUGS. II. SOME PROBLEMS RELATED TO THEIR USE].

Authors:  P RAJOTTE
Journal:  Can Med Assoc J       Date:  1964-08-15       Impact factor: 8.262

2.  Some aspects of an office practice utilizing LSD 25.

Authors:  A T BUTTERWORTH
Journal:  Psychiatr Q       Date:  1962-10

3.  The history and present-day use of ergot.

Authors:  J C MOIR
Journal:  Can Med Assoc J       Date:  1955-05-15       Impact factor: 8.262

4.  Some related factors of the LSD 25 reaction.

Authors:  S SALVATORE
Journal:  Psychiatr Q       Date:  1960-04

5.  Analytic work with LSD 25.

Authors:  M CUTNER
Journal:  Psychiatr Q       Date:  1959-10

6.  The role of psychotropic drugs in individual therapy.

Authors:  R A SANDISON
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

7.  Drugs used in the management of epilepsy.

Authors:  H GARLAND
Journal:  Proc R Soc Med       Date:  1957-08

8.  [Effect of d-lysergic acid diethylamide and 5-hydroxytryptamine on guppy Poecilia reticulatus chromatophores].

Authors:  A CERLETTI; B BERDE
Journal:  Experientia       Date:  1955-08-15

9.  An Experiment with a Psychiatric Night Hospital.

Authors:  J Bierer; I W Browne
Journal:  Proc R Soc Med       Date:  1960-11

10.  Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.

Authors:  F C Colpaert; T F Meert; C J Niemegeers; P A Janssen
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.